Skip to main content

CICC Hosts Inaugural Embark Salon in Hong Kong, Launches International Asset Custody Offering

HONG KONG, July 31, 2026 (GLOBE NEWSWIRE) — On July 30, China International Capital Corporation (CICC) hosted the inaugural “Embark Salon” in Hong Kong, in collaboration with the Chinese Overseas Private Funds Association (COPFA) and the Hong Kong Limited Partnership Fund Association (HKLPA). Titled “Setting Sail Overseas: Exploring the Future of USD Funds,” the event brought together approximately 150 representatives from asset managers, institutional investors and professional services firms.  Chinese companies, institutions and individuals are facing significant opportunities to expand globally. Chinese asset managers can use Hong Kong as a strategic hub – offering their investment expertise to global allocators seeking exposure to China, while gaining valuable experience in serving Chinese capital as it seeks diversified...

Continue reading

Stablecoin Development Corporation Reports Second Quarter 2026 Financial Results

Staking revenue of $2.2 million for the quarter and $4.7 million for the first half of 2026  SDEV grew its SKY position to 2.29 billion tokens (approximately 10% of total SKY supply) and eliminated all remaining warrant liabilities from its balance sheetWEST PALM BEACH, Fla., July 31, 2026 (GLOBE NEWSWIRE) — Stablecoin Development Corporation (NYSE American: SDEV) (the “Company” or “SDEV”), an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems and providing public market access to the stablecoin economy, yesterday reported financial results for the second quarter and first half ended June 30, 2026. The Company filed its Quarterly Report on Form 10-Q with the Securities and Exchange Commission on July 30, 2026. For the second quarter of 2026, the Company reported staking...

Continue reading

Arbor Realty Trust Reports Second Quarter 2026 Results and Declares Dividend of $0.17 per Share

Company Highlights:GAAP net loss of $(37.3) million, or $(0.20) per diluted common share Distributable earnings1 of $0.10 per diluted common share, or $0.15 excluding $9.6 million of net realized losses from the resolution of certain legacy assets Generated ~$500 million of additional liquidity through two recent capital markets transactions with a portion of the proceeds used to:Repurchase $114.3 million of common stock at $5.42 per share, or 49% of book value in July 2026 Redeem $270 million of senior notes in July 2026Repurchased an additional $20.8 million of stock at $5.85 per share, or 53% of book value Declares cash dividend on common stock of $0.17 per share Servicing portfolio of ~$36.70 billion, agency loan originations of $1.08 billion Structured loan portfolio of ~$12.11 billion, originations of $689.0 million and runoff...

Continue reading

Steakholder Foods Ltd. Announces Up To $10.5 Million Private Placement

$3.5 million upfront with up to approximately $7 million of potential additional gross proceeds upon the exercise in full of warrants Rehovot, Israel, July 31, 2026 (GLOBE NEWSWIRE) — Steakholder Foods Ltd. (Nasdaq: STKH) (“Steakholder Foods” or the “Company”), a global leader in 3D-printing technology for production of whole cuts of plant-based meat, today announced the entry into the definitive agreements for purchase and sale of an aggregate of 1,750,000 American Depositary Shares (“ADSs”) (or ADS equivalents in lieu thereof), each ADS representing twelve thousand (12,000) ordinary shares of the Company, short-term Series E warrants to purchase up to an aggregate of 1,750,000 ADSs and Series F warrants to purchase up to an aggregate of 1,750,000 ADSs, at a combined purchase price of $2.00 per ADS (or ADS equivalent in lieu...

Continue reading

Scientific Paper Detailing Preclinical Studies of Narmafotinib in Pancreatic Cancer Now Online

HIGHLIGHTSA manuscript describing comprehensive preclinical studies of narmafotinib in models of pancreatic cancer is now available online.The findings provide further evidence of narmafotinib’s ability to target several important drivers of pancreatic cancer progression, including fibrosis, chemotherapy resistance and metastatic spread.Melbourne, Australia, July 31, 2026 (GLOBE NEWSWIRE) — Amplia Therapeutics Limited (ASX:ATX; OTCQB:INNMF), (“Amplia” or the “Company”), announces that a scientific manuscript detailing extensive preclinical studies of narmafotinib in pancreatic cancer has been made publicly available on the biology preprint server bioRxiv and can be accessed via this link1. The manuscript describes research conducted by Professor Paul Timpson and colleagues at the Garvan Institute of Medical Research,...

Continue reading

MCN Adjourns Special Meeting of Shareholders Until August 26, 2026

CHICAGO, July 31, 2026 (GLOBE NEWSWIRE) — XA Investments, LLC, manager of XAI Madison Equity Premium Income Fund (MCN) (the “Fund”) announced it has adjourned the Fund’s Special Meeting of Shareholders (the “Meeting”) due to a lack of quorum. Shareholders are urged to please submit their votes on the proposal to approve a new sub-advisory agreement for the Fund as soon as possible. The Meeting will reconvene on Thursday, August 26, 2026, at 8:45 a.m. Central Time, at the offices of XA Investments, LLC at 321 N Clark St #2430, Chicago, Illinois. Shareholders of record of the Fund as of the close of business on June 2, 2026, are entitled to vote at the Meeting. Whether or not shareholders plan to attend the Meeting, it is important that their shares be represented and voted at the Meeting. How to Vote Use one of the following options...

Continue reading

Correction notice on partial early redemption of bonds

Vilnius, Lithuania, July 31, 2026 (GLOBE NEWSWIRE) — On 31 July 2026, SUTNTIB AB Tewox (hereinafter – the Company) published a notice on the partial early redemption of bonds. With this notice, the Company corrects the date of the partial early redemption of the bond issue (ISIN LT0000409567). The corrected date is 24 August 2026 (previously stated as 24 August 2025). The attached signed notice has also been revised accordingly, and the corrected version is attached. Contact person for further information: Paulius NevinskasManager of the Investment Companypaulius.nevinskas@lordslb.lthttps://lordslb.lt/tewox_bonds/AttachmentTewox notice on early redemption of bonds 2026-07-31

Continue reading

Hudbay Announces Correction to its Upcoming Dividend Record and Payment Dates

TORONTO, July 31, 2026 (GLOBE NEWSWIRE) — Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) announced today a correction to the record date and payment date for its upcoming quarterly cash dividend to be paid in September 2026. Hudbay’s news release dated July 29, 2026 included a typographical error and the record and payment dates contained therein should be disregarded. The corrected dates are set out below in the paragraph titled “Dividend Declared”: Dividend Declared A quarterly dividend of C$0.01 per share was declared on July 28, 2026. The dividend will be paid out on September 25, 2026 to shareholders of record as of close of business on September 8, 2026. Other than the corrections to the record date and payment date, all other terms of the quarterly cash dividend to be paid in September 2026 remain unchanged. Forward-Looking...

Continue reading

Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended June 30, 2026 and Declaration of Distributions on Common Stock for the Months Ending October 31, November 30, and December 31, 2026

GREENWICH, Conn., July 31, 2026 (GLOBE NEWSWIRE) — Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQG) (NasdaqGS: OXSQH) (the “Company,” “we,” “us” or “our”) announced today its financial results and related information for the quarter ended June 30, 2026. ·On July 29, 2026, our Board of Directors declared the following distributions on our common stock:Month Ending Record Date Payment Date Amount Per ShareOctober 31, 2026 October 16, 2026 October 30, 2026 $0.035November 30, 2026 November 16, 2026 November 30, 2026 $0.035December 31, 2026 December 17, 2026 December 31, 2026 $0.035       Net asset value (“NAV”) per share as of June 30, 2026 stood at $1.29, compared with a NAV per share on March 31, 2026 of $1.32. Net investment income (“NII”) was approximately $5.1 million, or $0.05 per share, for...

Continue reading

Dragonfly Energy Announces Strategic Acquisition of Dakota Lithium Assets, Expanding Into New Markets

Capital-efficient acquisition adds an established revenue base with expected Adjusted EBITDA accretion beginning in Q4 2026Acquisition expands Dragonfly Energy’s reach across marine, outdoor recreation, powersports, golf cart and other specialty battery markets Dakota Lithium generated approximately $12 million in net revenue in 2025 despite working-capital and inventory constraints that significantly limited product availability Expected to begin contributing meaningful revenue and be accretive to Adjusted EBITDA in the fourth quarter of 2026 $4 million purchase price includes $1 million in cash, with the remaining consideration paid in Dragonfly Energy common stock valued at $2.00 per share, a premium to recent trading levels Concurrent lender amendments provide additional financial flexibilityRENO, Nev., July 31, 2026 (GLOBE...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.